Northland analyst Carl Byrnes initiated coverage of TriSalus Life Sciences (TLSI) with an Outperform rating and $12.50 price target
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter